Maura Linda Sitanggang, director general at the Indonesian Ministry of Health, discusses the plans being rolled out to ensure that all Indonesians have access to medicines and how the Indonesian pharmaceutical industry has developed its self-reliance and innovativeness.
How does the Ministry of Health organize its priorities and how far along have you come towards reaching the initial goals since you assumed your position as director general last year?
"The universal healthcare system (JKN) has been as efficient partner as we could have hoped for."
